Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer.
Reads0
Chats0
TLDR
In this article, the authors discuss the mechanisms of normal and deregulated nuclear factor-erythroid 2-related factor 2 (NRF2) signaling pathway focusing on its cancer-related functions.Abstract:
Cancer is one of the most fatal diseases with an increasing incidence and mortality all over the world. Thus, there is an urgent need for novel therapies targeting major cancer-related pathways. Nuclear factor-erythroid 2-related factor 2 (NRF2) and its major negative modulator Kelch-like ECH-associated protein 1 (KEAP1) are main players of the cellular defense mechanisms against internal and external cell stressors. However, NRF2/KEAP1 signaling pathway is dysregulated in various cancers, thus promoting tumor cell survival and metastasis. In the present review, we discuss the mechanisms of normal and deregulated NRF2 signaling pathway focusing on its cancer-related functions. We further explore activators and inhibitors of this pathway as cancer targeting drug candidates in order to provide an extensive background on the subject.read more
Citations
More filters
Journal ArticleDOI
Rutin (Bioflavonoid) as Cell Signaling Pathway Modulator: Prospects in Treatment and Chemoprevention.
TL;DR: In this article, the potential of rutin in the modulation of several key cellular functions via interaction with mRNAs, with major emphasis on elucidating direct miRNA targets of Rutin as well as the process needed to transform these approaches for developing novel therapeutic interventions for the treatment of several cancers.
Journal ArticleDOI
Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment
TL;DR: The attributes associated with Nrf2 in the development of drug resistance, angiogenesis, cancer stem cell generation, and metastasis in the specific context of breast cancer are discussed and the therapeutic strategies employed against breast cancer exploiting NRF2 signaling cascades are discussed.
Journal ArticleDOI
An update of Nrf2 activators and inhibitors in cancer prevention/promotion
TL;DR: In this paper , a review of NF-E2-related factor 2 (Nrf2) inducers and inhibitors and their chemopreventive and/or anticancer activities is presented.
Journal ArticleDOI
An update of Nrf2 activators and inhibitors in cancer prevention/promotion
TL;DR: In this article , a review of NF-E2-related factor 2 (Nrf2) inducers and inhibitors and their chemopreventive and/or anticancer activities is presented.
Journal ArticleDOI
The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19.
Sonia Emanuele,Adriana Celesia,Antonella D'Anneo,Marianna Lauricella,Daniela Carlisi,Anna De Blasio,Michela Giuliano +6 more
TL;DR: In this paper, the role of Nrf2 in cancer and COVID-19, two widespread diseases that represent a cause of major concern today, has been discussed and a review describes the molecular aspects of NRF2 signalling in both pathological situations and the most recent findings about the advantages of NNF2 inhibition or activation as possible strategies for cancer and CoVID-9 treatment respectively.
References
More filters
Journal ArticleDOI
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray,Jacques Ferlay,Isabelle Soerjomataram,Rebecca L. Siegel,Lindsey A. Torre,Ahmedin Jemal +5 more
TL;DR: A status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions.
Journal ArticleDOI
Hallmarks of cancer: the next generation.
TL;DR: Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Journal ArticleDOI
Oncomirs — microRNAs with a role in cancer
TL;DR: Evidence has shown that miRNA mutations or mis-expression correlate with various human cancers and indicates that miRNAs can function as tumour suppressors and oncogenes.
Journal ArticleDOI
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay,Murielle Colombet,Isabelle Soerjomataram,Colin Mathers,Donald Maxwell Parkin,Marion Piñeros,Ariana Znaor,Freddie Bray +7 more
TL;DR: The sources and methods used in compiling the cancer statistics in 185 countries are reviewed, and uncertainty intervals are now provided for the estimated sex‐ and site‐specific all‐ages number of new cancer cases and cancer deaths.
Journal ArticleDOI
ROS Function in Redox Signaling and Oxidative Stress
TL;DR: It is argued that redox biology, rather than oxidative stress, underlies physiological and pathological conditions.